Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization

NCT00512876 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

FED

Sponsor class

Conditions

Corneal Neovascularization

Interventions

DRUG: Bevacizumab (Avastin)

Sponsor

Walter Reed Army Medical Center

Collaborators

[object Object]